Y-Intercept (HK)
REGN icon

Y-Intercept (HK)’s Regeneron Pharmaceuticals REGN Stock Holding History

Y-Intercept (HK)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.6M Buy
25,842
+22,644
+708% +$17.1M 0.43% 18
2026
Q2 		$1.99M Buy
+3,198
New +$2.18M 0.04% 704
2025
Q4 		– Sell
-10,318
Closed -$5.8M – 1924
2025
Q3 		$5.8M Sell
10,318
-24,556
-70% -$13.9M 0.14% 165
2025
Q2 		$18.3M Buy
34,874
+25,170
+259% +$14M 0.45% 12
2025
Q1 		$6.15M Sell
9,704
-1,821
-16% -$1.25M 0.42% 37
2024
Q4 		$8.21M Buy
11,525
+2,100
+22% +$1.76M 0.55% 12
2024
Q3 		$9.9M Buy
+9,425
New +$10.5M 0.61% 12
2024
Q2 		– Sell
-1,967
Closed -$1.89M – 1834
2024
Q1 		$1.89M Sell
1,967
-1,218
-38% -$1.16M 0.14% 181
2023
Q4 		$2.8M Buy
+3,185
New +$2.62M 0.26% 75
2023
Q3 		– Sell
-2,221
Closed -$1.6M – 1500
2023
Q2 		$1.6M Buy
+2,221
New +$1.71M 0.17% 151
2023
Q1 		– Sell
-1,107
Closed -$799K – 1474
2022
Q4 		$799K Buy
+1,107
New +$817K 0.12% 267
2022
Q3 		– Sell
-847
Closed -$501K – 1220
2022
Q2 		$501K Sell
847
-1,010
-54% -$657K 0.07% 426
2022
Q1 		$1.3M Buy
+1,857
New +$1.17M 0.3% 71
2021
Q4 		– Sell
-4,133
Closed -$2.5M – 832
2021
Q3 		$2.5M Sell
4,133
-73
-2% -$45.3K 0.45% 33
2021
Q2 		$2.35M Buy
+4,206
New +$2.13M 0.6% 16

Other funds holding REGN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Y-Intercept (HK)'s REGN Position: Q3 2026 in Review

Y-Intercept (HK) increased its Regeneron Pharmaceuticals (REGN) stake by 708% in Q3 2026, buying an estimated $17.1M and bringing the position to 25,842 shares worth $19.6M. The position accounts for 0.43% of the portfolio, ranked #18.

Y-Intercept (HK) first reported a position in REGN in Q2 2021 and has held it in 15 quarters since. 817 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Y-Intercept (HK) held 25,842 shares of Regeneron Pharmaceuticals worth $19.6M as of Q3 2026.
  • Y-Intercept (HK) bought 22,644 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $17.1M.
  • Regeneron Pharmaceuticals made up 0.43% of Y-Intercept (HK)'s portfolio in Q3 2026, its #18 holding.
  • Y-Intercept (HK) first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
  • 817 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.